Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-11-08
Original SEC Filing: Click here

---

Webplus: SVA/20161108/6-K/2_EX-99.1/000.htm SEC Original: v452499_ex99-1.htm
Sinovac Announces Results of 2016 Annual General Meeting of Shareholders BEIJING, November 7, 2016 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company’s 2016 Annual General Meeting of Shareholders held on Monday, November 7, 2016 in Beijing, PRC. The required quorum, a majority of the common shares outstanding,

---

---

Webplus: SVA/20161108/6-K/1/000.htm SEC Original: v452499_6k.htm
FORM 6-K ————– ———- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v452499_6k.htm FORM 6-K

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-11-08CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085